Francis Takes Stock Of Teva Ahead Of Revealing Fresh Strategy

Generics Uptick In Europe And Internationally Helps Offset North America Slide

 
• By Dave Wallace

As Teva prepares to unveil a fresh strategy under new CEO Richard Francis on 18 May, the company has delivered Q1 results along with an update on planned US launches for long-acting injectable risperidone as well as biosimilar adalimumab.

Empty stage with red curtains and spotlight
The stage is set for Teva’s strategy reveal on 18 May • Source: Shutterstock

More from Earnings

More from Business